Comelec chief victim of ‘salisi gang’ in Pasay City restaurant
PHILHEALTH announces the nationwide launch of the enhanced PhilHealth Guaranteed and Accessible Medications for Outpatient Treatment (PhilHealth Gamot), a comprehensive outpatient drug benefit package that covers essential medicines. The program will take effect on Aug. 21, 2025, under PhilHealth Circular 2025-0013.
FREE MEDICINES PhilHealth launches the enhanced PhilHealth Gamot program, offering free outpatient essential medicines for common treatments starting Aug. 21, 2025. PHOTO FROM PHILHEALTH PhilHealth Gamot is a key component of the PhilHealth Yakap Program, which the President announced in his recent State of the Nation Address, underscoring the vision of a healthier Philippines.
PhilHealth Gamot includes 75 types of free medicines with an annual benefit limit of P20,000 per beneficiary.
These medications are common treatments for a wide range of conditions, such as infections (anti-microbial), asthma and COPD, diabetes, high cholesterol (dyslipidemia), high blood pressure and heart conditions (cardiology), and nervous system disorders, along with other supportive therapies.
To avail of the PhilHealth Gamot, members should be registered in their PhilHealth Yakap Clinic of choice. Following a thorough medical assessment, their primary care doctor will then issue a prescription containing a Unique Prescription Security Code as necessary.
Get the latest news
delivered to your inbox Sign up for The Manila Times newsletters By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
The beneficiary can then proceed to any Gamot Facility and show the prescription and present any government-issued ID card.
The accredited Gamot Facilities are Vidacure with branches in Muntinlupa City and Quezon City; Pharma Gen Ventures Corp. (Generika Drugstore) with branches in Parañaque City, Navotas City, Quezon City and Taguig City; CGD Medical Depot Inc. at Vertis North; and Chinese General Hospital.
Advertisement
